当前位置: 首页 > 期刊 > 《中华现代外科学杂志》 > 2005年第14期
编号:10741911
ATP-生物荧光法在消化系恶性实体肿瘤体外药物敏感性的应用
http://www.100md.com 《中华现代外科学杂志》 2005年第14期
生物荧光法,,ATP-生物荧光法;恶性实体肿瘤;化疗,1资料与方法,2结果,3讨论,【参考文献】
     【摘要】 目的 探讨ATP-生物荧光法(ATP-TCA系统)在消化道恶性实体肿瘤体外药物敏感性试验中的应用。方法 取肝癌、胃癌、直肠癌、结肠癌共39例患者的手术标本,应用ATP-TCA系统方法做药物敏感性试验。

    结果 ATP-TCA的可评估率为92.31%;6种试验用化疗药物的敏感率分别为:丝裂霉素12.50%,紫杉醇23.33%,顺铂30.77%,羟喜树碱42.31%,5-氟尿嘧啶51.85%,表阿霉素61.54%。结论 ATP-生物荧光法可用于消化道恶性实体肿瘤化疗药物的筛选。

    【关键词】 ATP-生物荧光法;恶性实体肿瘤;化疗

    Application of ATP-bioluminescence assay for screening chemotherapeutic agents of digestive tract malignant solid tumor

    SU Cheng-wu,TANG Yong-mei,CAI Jie,et al.

    The Medical Scientific Research Center of Guangxi Medical University,Nanning 530021,China

    【Abstract】 Objective To study the application of the ex vivo ATP-bioluminescence assay(ATP-TCA) in the chemotherapy of digestive tract malignant solid tumor.Methods The surgical specimens of 39 patients,including primary liver cancer,gastric carcinoma,colic and rectal carcinoma,were tested by the ATP-TCA.Results Evaluable test results were achieved in 36 of 39 patients,the evaluability rate was 92.31%.The sensitive rates of mitomycin C (MMC),paclitaxel (TXL),cisplatin (CDDP),camptothece (HCT),5-fluoruracil (5-FU),epirubicin (EPI),was 12.50%,23.33%,30.77%,42.31%,51.85%,61.54%,respectively.Conclusion ATP-TCA is a good option in the chemotherapeufic agents screening of digestive duct malignant solid tumor. ......

您现在查看是摘要页,全文长 6645 字符